Tempus AI, Inc. (NASDAQ:TEM) CEO Sells $5,428,601.64 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 80,388 shares of the firm’s stock in a transaction on Friday, February 7th. The shares were sold at an average price of $67.53, for a total transaction of $5,428,601.64. Following the completion of the sale, the chief executive officer now owns 5,293,005 shares in the company, valued at $357,436,627.65. The trade was a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Tempus AI Stock Performance

TEM stock opened at $68.96 on Monday. The company has a fifty day moving average price of $44.49 and a 200 day moving average price of $49.16. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $79.49.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on TEM shares. Needham & Company LLC restated a “buy” rating and issued a $56.00 price target on shares of Tempus AI in a research note on Tuesday, January 14th. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and raised their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Guggenheim started coverage on Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Loop Capital cut their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Finally, Piper Sandler restated a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Tempus AI currently has a consensus rating of “Moderate Buy” and a consensus target price of $58.55.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Vestmark Advisory Solutions Inc. increased its holdings in shares of Tempus AI by 148.3% in the fourth quarter. Vestmark Advisory Solutions Inc. now owns 122,450 shares of the company’s stock valued at $4,134,000 after purchasing an additional 73,132 shares during the period. Raymond James Financial Inc. acquired a new position in Tempus AI in the 4th quarter valued at $3,757,000. Victory Capital Management Inc. acquired a new position in Tempus AI in the 4th quarter valued at $216,000. SBI Securities Co. Ltd. purchased a new position in Tempus AI during the 4th quarter worth $673,000. Finally, US Bancorp DE acquired a new stake in shares of Tempus AI in the 4th quarter worth $80,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.